Opens in a new tab
Lean Seal ISO website iv removebg
ALWAYS AUDIT READY
Feasibility Inquiry

Oncology Experience

Experience by Indication

Solid Tumors

Central Nervous System (CNS) Tumors

  • Anaplastic Astrocytoma
  • Glioblastoma
  • Primary Central Nervous System Lymphoma (PCNSL)*
  • Pediatric Solid Tumors

Thoracic Malignancies

  • Non–Small Cell Lung Cancer (NSCLC)
    • Lung Adenocarcinoma
    • Squamous NSCLC
  • Small Cell Lung Cancer (SCLC)
  • Neuroendocrine Tumors (Advanced)

Breast and Gynecologic Malignancies

  • Breast Cancer
  • Ovarian Cancer
  • Fallopian Tube Cancer
  • Primary Peritoneal Cancer
  • Endometrial Cancer
  • Cervical Cancer

Genitourinary Malignancies

  • Prostate Cancer
    • Castration-Resistant Prostate Cancer (CRPC)
  • Renal Cell Carcinoma (RCC)
  • Bladder Cancer
  • Urothelial Carcinoma

Gastrointestinal Malignancies

  • Colorectal Cancer
  • Gastric Cancer
  • Pancreatic Cancer
  • Hepatocellular Carcinoma (Liver Cancer)
  • Gastrointestinal Stromal Tumor (GIST)

Head and Neck Malignancies

  • Head and Neck Squamous Cell Carcinoma (HNSCC)

Skin and Soft Tissue Malignancies

  • Basal Cell Carcinoma
  • Melanoma
    • Mucosal Melanoma

Early Phase / Basket Studies

  • Phase I Solid Tumors
  • Rare Solid Tumors

Hematologic Malignancies

Leukemias

  • Chronic Lymphocytic Leukemia (CLL)
  • Chronic Myeloid Leukemia (CML)
  • Chronic Myelomonocytic Leukemia (CMML)
  • Acute Myeloid Leukemia (AML)

Lymphomas

  • Non-Hodgkin Lymphoma (NHL)
    • Follicular Lymphoma (FL)
    • Diffuse Large B-Cell Lymphoma (DLBCL)
    • Small Lymphocytic Lymphoma (SLL)
    • Mantle Cell Lymphoma (MCL)
    • Marginal Zone Lymphoma (MZL)
    • Lymphoplasmacytic Lymphoma
    • Mature B-Cell Lymphomas
    • Peripheral T-Cell Lymphoma (PTCL)
    • Cutaneous T-Cell Lymphoma (CTCL)
    • Indolent B-Cell Lymphomas

Plasma Cell and Bone Marrow Disorders

  • Multiple Myeloma
  • Myelodysplastic Syndromes (MDS)

Early Phase / Basket Studies

  • Phase I Hematologic Malignancies

Non-Oncology / Supportive Care

  • Mild Respiratory Distress**

Experience by Drug Modalities

  • Antiangiogenic small molecules
  • Antigen Presenting Cell (APC)
  • Anti-metabolite
  • Antibody Drug Conjugates (ADC)
  • Biomarker
  • Chemotherapy
  • Cytotoxics
  • Fusion proteins / Engineered biologics
  • Gene therapies
  • Glutaminase inhibitors
  • Hormones
  • Hedgehog pathway inhibitors
  • Immunotherapeutic product obtained from leukapheresis
  • Monoclonal antibodies (mAb)
  • Live biotherapeutic product (LBP)
  • Oncologic vaccine
  • Oligonucleotide
  • Opioid
  • Oxygen carriers / Nanoparticles
  • Peptides
  • Photosensitizing agent
  • Radiopharmaceuticals
  • Radioactive imaging agent
  • Radioligand Therapeutics
  • Recombinant DNA (single-strand DNA)
  • Retroviral replicating vector
  • Small molecules
  • (Stem) cell therapies
  • Vaccines

Clinical Team Experience

  • Solid tumors / hematologic malignancies
  • Registrational trials
  • Dose escalation / first-in-human studies
  • Basket trials
  • Biomarker-driven patient selection
  • Radionuclide therapeutics products
  • Radiopharmacies
  • Rare diseases
  • Pediatric population
  • Inspections by regulatory agencies